Affinity selection mass spectrometry (AS-MS) was recently applied to a new high-throughput binder confirmation (HTBC) platform. The HTBC-AS-MS platform can assess target engagement for hundreds of chemical series per target and is used at GSK to prioritize synthesis decisions for follow-up organic synthesis of DNA-encoded library technology (ELT) hits.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/978-1-0716-2545-3_25 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!